Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CO › Grand Junction › NPI 1699716027
Transport

ST. Mary's Hospital and Medical Center, INC.

ST. Mary's Hospital and Medical Center, INC. was paid $14.49M by Medicaid between Jan 2018 and Dec 2024, across 224 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.

33Billing provider infoST. MARY'S HOSPITAL AND MEDICAL CENTER, INC.
GRAND JUNCTION, CO 81501
33aNPI1699716027assigned 06/09/2006
33bProvider typeAmbulance
28Total paid$14.49M
24GClaims678,653
24DCodes billed224
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ambulance providers in Colorado

Rank by total paid#2 of 58
Median peer was paid$115K
This provider vs. median126×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018124,183$2.62M
2019137,431$2.89M
202090,681$1.81M
202187,348$1.95M
202283,765$1.36M
202390,205$2.15M
2024incomplete65,040$1.72M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 27,414 25,139 $3.05M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 16,307 14,368 $1.83M
74177 Computed tomography, abdomen and pelvis; with contrast material 6.6% 2,783 2,367 $957K
96361 Intravenous infusion, hydration; each additional hour 5.0% 6,434 4,647 $729K
70450 Computed tomography, head or brain; without contrast material 3.9% 3,619 3,028 $572K
80053 Comprehensive metabolic panel 3.8% 56,016 44,703 $553K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.6% 5,601 3,679 $522K
J3490 Unclassified drugs 3.0% 120,901 44,922 $428K
A0430 Ambulance service, conventional air services, transport, one way (fixed wing) 2.6% 156 139 $384K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.5% 3,262 2,659 $365K
96375 Therapeutic injection; each additional sequential IV push 1.7% 14,221 10,747 $250K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.7% 9,160 3,110 $250K
212 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 73,598 $232K
76700 Ultrasound, abdominal, real time with image documentation; complete 1.4% 1,523 $201K
71046 Radiologic examination, chest; 2 views 1.3% 6,581 $192K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.2% 4,716 $171K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.1% 2,370 $157K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 1,792 $156K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,679 $144K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 18,667 $143K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,014 $133K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,733 $131K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,737 $102K
80048 Basic metabolic panel (calcium, ionized) <1% 7,437 $95K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 275 $94K
76830 Ultrasound, transvaginal <1% 906 $94K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,176 $84K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,393 $84K
84443 Thyroid stimulating hormone (TSH) <1% 7,255 $79K
80320 <1% 1,131 $78K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 880 $74K
96376 <1% 2,618 $62K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 939 $60K
84484 <1% 4,176 $58K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,550 $55K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 832 $55K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,720 $54K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,633 $51K
A0431 Ambulance service, conventional air services, transport, one way (rotary wing) <1% 29 $48K
36415 Collection of venous blood by venipuncture <1% 23,975 $48K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 116 $47K
72125 Computed tomography, cervical spine; without contrast material <1% 522 $47K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,281 $47K
87653 <1% 1,262 $47K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,502 $46K
70551 Magnetic resonance imaging, brain; without contrast material <1% 138 $45K
86780 <1% 2,304 $42K
81001 <1% 14,373 $42K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,091 $39K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 112 $39K
80061 Lipid panel <1% 3,115 $39K
72100 <1% 799 $39K
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening <1% 2,305 $38K
90715 <1% 596 $37K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 3,114 $36K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 212 $32K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 570 $32K
87536 <1% 441 $31K
83036 Hemoglobin; glycosylated (A1C) <1% 2,548 $30K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 176 $30K
83690 <1% 8,728 $29K
86762 <1% 1,337 $27K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,106 $26K
80329 <1% 672 $25K
87340 <1% 1,926 $25K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 84 $23K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 961 $22K
81025 <1% 3,287 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 932 $20K
73030 <1% 669 $20K
86850 <1% 2,349 $20K
84702 <1% 1,967 $20K
84439 <1% 2,050 $19K
71275 Computed tomographic angiography, chest, with contrast material <1% 89 $19K
71045 Radiologic examination, chest; single view <1% 4,286 $19K
86140 <1% 1,731 $18K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 57 $18K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,367 $18K
73630 <1% 638 $16K
77067 Screening mammography, bilateral, including computer-aided detection <1% 932 $16K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 902 $15K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,163 $15K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,618 $15K
85610 <1% 4,641 $14K
82570 <1% 1,455 $14K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,120 $13K
76801 <1% 154 $13K
J7050 Infusion, normal saline solution, 250 cc <1% 11,252 $13K
82728 <1% 1,003 $12K
73562 <1% 449 $12K
73610 <1% 470 $12K
73130 <1% 445 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 160 $10K
97161 <1% 70 $10K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,211 $9K
85027 <1% 2,099 $9K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 92 $8K
87081 <1% 553 $8K
87186 <1% 1,055 $8K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,905 $8K
80306 <1% 1,339 $8K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 809 $8K
83540 <1% 1,047 $8K
83550 <1% 999 $7K
82565 <1% 2,880 $7K
70498 <1% 17 $7K
76770 <1% 52 $7K
76642 <1% 85 $7K
86900 <1% 2,401 $6K
86901 <1% 2,404 $6K
87088 <1% 652 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,690 $6K
82607 <1% 484 $5K
99213 Doctor's office visit, returning patient (routine) <1% 550 $5K
83735 <1% 999 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,130 $5K
82962 <1% 3,923 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 11,349 $5K
83880 <1% 186 $5K
83605 <1% 516 $5K
85379 <1% 480 $4K
96367 <1% 157 $4K
84156 <1% 708 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,750 $4K
85652 <1% 1,438 $4K
82950 <1% 780 $4K
97162 <1% 161 $3K
76536 <1% 30 $3K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 43 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,214 $3K
36591 <1% 200 $3K
83615 <1% 644 $3K
83516 <1% 119 $3K
87070 <1% 292 $2K
70496 <1% 14 $2K
88342 <1% 124 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,630 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,486 $2K
73110 <1% 86 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 27 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,347 $2K
82947 <1% 1,073 $2K
80076 <1% 401 $2K
80325 <1% 17 $2K
85730 <1% 459 $2K
82670 <1% 214 $2K
87147 <1% 345 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 132 $2K
J2560 Injection, phenobarbital sodium, up to 120 mg <1% 137 $2K
82784 <1% 94 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 749 $1K
88304 <1% 46 $1K
97163 <1% 27 $1K
73502 <1% 40 $1K
J2704 Injection, propofol, 10 mg <1% 3,067 $1K
84550 <1% 344 $1K
84481 <1% 93 $1K
80359 <1% 17 $1K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 422 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,749 $1K
74018 <1% 26 $1K
82043 <1% 27 $942.62
A0425 Ground mileage, per statute mile <1% 24 $870.84
86360 <1% 32 $854.63
87205 <1% 227 $837.31
86359 <1% 32 $834.42
84703 <1% 685 $823.66
87040 <1% 105 $704.16
J1630 Injection, haloperidol, up to 5 mg <1% 2,247 $645.67
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,304 $643.13
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,326 $576.69
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 32 $576.62
86038 <1% 41 $570.18
80349 <1% 30 $557.27
87486 <1% 12 $554.46
80159 <1% 90 $552.59
97166 <1% 15 $520.68
80348 <1% 15 $496.15
82746 <1% 40 $464.17
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 24 $450.52
77065 Tomosynthesis, mammo <1% 19 $443.40
72110 <1% 13 $415.53
99214 Doctor's office visit, returning patient (more involved) <1% 16 $379.81
84403 <1% 90 $346.44
36416 <1% 210 $342.25
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,002 $322.53
85007 <1% 59 $322.04
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 644 $291.56
80074 <1% 32 $285.72
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 96 $283.68
87581 <1% 12 $277.19
86706 <1% 43 $268.87
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 12 $225.26
87210 <1% 66 $208.08
82105 <1% 26 $182.96
97597 <1% 16 $167.31
87077 <1% 20 $152.57
86704 <1% 27 $151.41
84100 <1% 59 $133.31
86361 <1% 12 $131.02
85018 <1% 49 $113.72
88300 <1% 14 $103.34
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 39 $77.92
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 224 $72.23
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 26 $54.67
86364 <1% 33 $43.28
85014 <1% 12 $42.42
90686 <1% 20 $41.03
J1644 Injection, heparin sodium, per 1000 units <1% 168 $21.67
J0780 Injection, prochlorperazine, up to 10 mg <1% 18 $18.88
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 413 $17.22
J3411 Injection, thiamine hcl, 100 mg <1% 36 $15.43
J0461 Injection, atropine sulfate, 0.01 mg <1% 30 $8.92
J2060 Injection, lorazepam, 2 mg <1% 285 $8.40
J3475 Injection, magnesium sulfate, per 500 mg <1% 17 $6.39
A9270 Non-covered item or service <1% 3,956 $5.13
J1815 Injection, insulin, per 5 units <1% 35 $1.14
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 257 $0.00
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 0% 13 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 91 $0.00
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 0% 148 $0.00
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study 0% 428 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 0% 81 $0.00
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDONOHUE, VINCENT (AVP FINANCE)
Parent organizationSISTERS OF CHARITY OF LEAVENWORTH HEALTH SYSTEM, INC